With the shutdown of Pocket approaching, users must find new ways to save their favorite articles. Here’s a roundup of the best alternatives, from Matter to Instapaper and more, to ensure your reading list remains intact.
Have you noticed people blasting their phone conversations in public? Discover the reasons behind this trend, the myths about headphones, and how affordable audio solutions can change everything!
The first day of a NJ Transit strike left thousands of commuters in confusion at Newark Penn Station, scrambling for alternate transport options. With no trains running, many riders faced exorbitant fares and uncertain journeys.
With a midnight deadline approaching, NJ Transit riders face significant disruptions as a potential rail strike looms for the first time in over 40 years. Commuters scramble for alternatives, fearing steep costs and inconvenience.
Recent studies reveal vast hydrogen reservoirs hidden beneath the Earth, potentially meeting energy needs for 170,000 years. Learn about the geological conditions that facilitate this natural hydrogen production and the companies racing to tap into it.
In a bold experiment, Ramon van Meer tested whether American consumers would pay more for products made in the USA. The results were surprising and revealed a stark preference for cheaper, imported alternatives. Discover the insights he gained!
As Microsoft prepares to end support for Windows 10 on October 14, 2025, millions risk using an outdated OS. Discover your options, from upgrading to Windows 11 to exploring alternatives like ChromeOS and Linux.
Microsoft has discontinued its $999 entry-level Surface Pro 11 and Surface Laptop 7 configurations, replacing them with cheaper models. The new Surface Pro 12 and Laptop 13 start at $799 and $899, prompting speculation about pricing strategies.
After 23 years, Skype is shutting down! Learn how to migrate to Microsoft Teams or explore alternatives like Google Meet and Zoom. Don’t lose your contacts and data—transition smoothly!
A groundbreaking study reveals that immunotherapy drug dostarlimab has led to remarkable tumor disappearance in cancer patients, offering a new hope for those battling solid tumors.
